Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss) from operations	$ (6,392,270)	$ (4,216,669)
Changes in derivatives and mark-to-market	(121,030)	(1,485,011)
Stock issuance for cancellation of debts, warrant exercises and service	2,404,786	3,793,473
Adjustment for funds in transit		2,500
(Increase) decrease in assets and prepaid expenses
Deferred financing costs	197,366	113,440
Other (increase) decrease in assets and prepaid expenses	(82,913)	7,000
Increase (decrease) in accounts payable and accrued expenses
Accounts payable	5,035	(400)
Accrued expenses (net)	807,680	224,793
Sub-fund obligations and contingency commitments	(69,450)	108,684
Advances from customers and client deposits	20,169	95,000
Net cash provided by (used in) operating activities	(3,230,627)	(1,357,190)
Cash flows from investing activities:
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Common Stock	1,122,224	251,800
Common Stock to be issued	1,084,290	396,000
Loans and Notes Payable	1,046,092	680,919
Net cash provided by (used in) financing activities	3,252,606	1,328,719
Net decrease in cash and cash equivalents	21,980	(28,471)
Cash and cash equivalents, beginning of period	19,765	67,896
Cash and cash equivalents, end of period	$ 41,745	$ 39,424